BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medtech Medical Diagnostic

EU Approves HUTCHMED's FRUZAQLA® for Previously Treated Metastatic Colorectal Cancer

— Approval for previously treated metastatic colorectal cancer based on results from positive, global, Phase III FRESCO-2 Trial — — FRUZ...

June 24, 2024 | News

Gilead Sciences Announces 100% Efficacy in Phase 3 PURPOSE 1 Trial for HIV Prevention in Cisgender Women

Gilead Sciences, Inc. announced topline results from an interim analysis of its pivotal Phase 3 PURPOSE 1 trial, demonstrating that the company’s twi...

June 21, 2024 | News

GE HealthCare and MediView XR Launch First OmnifyXR Interventional Suite in Minneapolis

GE HealthCare a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, and MediView XR Inc., a leading clinical au...

June 21, 2024 | News

CMT Research Foundation Partners with ReviR Therapeutics to Pioneer Oral Small Molecule Therapy for CMT1A

The CMT Research Foundation, a non-profit focused solely on delivering treatments and cures for Charcot-Marie-Tooth disease (CMT)*, has formed a strat...

June 20, 2024 | News

WS Audiology to Open Cutting-Edge Audiological Research Laboratory in Singapore

WS Audiology (WSA), a global leader in the hearing aid industry, t announced it is opening an audiological research laboratory in Singapore. Su...

June 18, 2024 | News

Ochre Bio and GSK Enter Multi-Year Partnership to Advance Liver Disease Research

Ochre Bio, a pioneer in chronic liver disease medicine development, has today announced the start of a multi-year data licence agreement with GSK. The part...

June 13, 2024 | News

GC Biopharma and Novel Pharma Receive FDA Fast Track Designation for Sanfilippo Syndrome Treatment GC1130A

GC Biopharma (006280. KS) and Novel Pharma have announced that the U.S. FDA has granted Fast Track Designation for their jointly developed MPSIIIA (Sanfili...

June 11, 2024 | News

Gilead and Kite Oncology Announce Approval of Yescarta® for Early Treatment of DLBCL in Singapore

**-- In ZUMA-7, Yescarta Patients with DLBCL were 2.5 Times More Likely than SOC to be Alive at Two Years Without Cancer Progression or Nee...

June 10, 2024 | News

GE HealthCare Debuts Advanced Precision Care Solutions at SNMMI Annual Meeting

GE HealthCare once again joins the world’s top medical and academic institutions at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) ann...

June 10, 2024 | News

EnGeneIC and Singapore Institute of Advanced Medicine Partner to Transform Cancer Treatment in Asia

EnGeneIC, a clinical-stage biopharmaceutical company pioneering the development of a First-in-Class targeted nanocell for cancer therapy has announce...

June 07, 2024 | News

Genetic Signatures Receives FDA Clearance for EasyScreen™ Gastrointestinal Parasite Detection Kit

Genetic Signatures Limited a global molecular diagnostics company announces that the US Food & Drug Administration ("FDA") has cleared the Compan...

June 05, 2024 | News

QIAGEN Launches Enhanced QIAstat-Dx Respiratory SARS-CoV-2 Panel in Malaysia

The CE-IVD marked QIAstat-Dx Respiratory SARS-CoV-2 Panel is available in Malaysia expanded to 23 pathogens, now includes Chlamydophila pneumoniae&nb...

June 04, 2024 | News

Thermo Fisher Scientific Announces IVDR Compliance for CytoScan Dx Assay and ChAS Dx Software, Enhancing Cytogenetic Testing in the EU

Thermo Fisher Scientific Inc., the world leader in serving science, announced today that the Applied Biosystems™ CytoScan™ Dx Assay and Applied...

May 31, 2024 | News

SK Telecom Launches AI-Based Veterinary X-Ray Service 'X Caliber' in Australia

In collaboration with ATX Medical Solutions, SKT launches X Caliber in Australia, which has one of the highest rates of pet ownership in the world ...

May 29, 2024 | News

Stay Connected